Home Neuralink Valued at $9 Billion Following $600M Funding Round as 'Telepathy' Brain-Computer Interface Nears Human Trials

Neuralink Valued at $9 Billion Following $600M Funding Round as 'Telepathy' Brain-Computer Interface Nears Human Trials

Jun 01, 2025 11:40 CST Updated 11:40
Neuralink

Brain-Computer Interface System Developer

图片
图片

Hot Topics and Highlights in the Global ADC Arena | Pharma Era Live Room



Image


Body:1529Character7Figure

Estimated Reading Time: 5Minute



On July 3, 2020, the official website of Drug Times (https://www.drugtimes.cn) published an article titled “Here it comes! He’s here! Tesla rides the wind and waves, breaking into the pharmaceutical industry!》, with nearly 30,000 views. This clearly demonstrates the high level of interest among readers in business visionary Elon Musk. Today, we are sharing another piece of breaking news on the “Pharma Era” WeChat official account.

Image


01

Highlights


NeuralinkCompleted6$100 million in financing, valuation90Hundreds of Millions: Human Implant Trials for Brain-Computer Interface Technology Imminent, Mind-Controlled Devices May Become a Reality in the Future

  1. Neuralink’s brain-computer interface technology aims to treat various neurological disorders through implanted chips.
  2. Neuralink’s technological vision extends beyond medical applications, with the potential to enhance human cognitive capabilities and augment both intellectual and physical capacities.
  3. Elon Musk looks forward to creating“AIEnhanced Humans



02

Outline


Neuralink Company Overview

  • Corporate Financing and Valuation:
    • Completion rate up to6hundred million dollars in a new round of financing, with the company's valuation reaching90hundred million USD.
    • Previously at2023Year8Monthly Completion2.8$100 millionDRound of financing.
  • Core Technology: Brain-Computer Interface (BMI):
    • Implant the wireless chip device into the human skull and connect it to the brain via electrode wires.
    • Aims to help patients with neurological disorders control external devices using only their thoughts.
  • Future Prospects:
    • Upgraded Brain-Computer Interface Chip“Blindsight”May be scheduled for2025First human implantation by year-end.
    • Plan2025will have in the year20-30patients received experimental implants.
    • Product No. 1Telepathy”(Telepathy)Aims to achieve control of devices such as smartphones and computers through thought.



03

Highlights


PharmaEra TechHey, I recently came across some really explosive news,NeuralinkMelted again6$100 million! Valuation skyrockets to90A hundred million! This guy specializes in...Brain-Computer Interface"What high-tech game are they playing, burning so much money?"

Drug Era BaiaoSpeaking ofNeuralinkAh, it’s actually quite fascinating. They essentially implant a wireless chip into your skull—more precisely, within the cranium—and connect it to your neural circuits using electrodes finer than a human hair, enabling you to directly control external devices with your thoughts.

PharmaEra TechTelekinetic control? That sounds way too cyberpunk! How exactly does it work? The implantation procedure...It sounds a bit creepy!

Drug Era BaiaoImplantation, in fact, is quite similar to neurosurgical procedures. First, a small hole is drilled into your skull to insert the chip, and then the electrode wires are threaded in like embroidery. “Wearto the surface of the brain, in intimate contact with neurons. You can imagine it as a wireless bridge—Bluetooth-enabled—between your brain and a computer.5.0The kind that sounds a bit scary, but think about it: if patients with neurological disorders could control the mouse and keyboard just by thinking, how much would their quality of life improve?levelAh!

Drug Era TechThe funds raised this time6Hundreds of millions of dollars—are they preparing to bring this thing to market?

Drug Era BaiaoThat’s right. They already conducted a round last August.DSeries financing, raised2.8hundred million US dollars, this time adding this6100 million, directly isEA major outbreak occurred. This funding is primarily intended to secure, in addition to continuing the optimization of hardware and surgical procedures.2025First-in-human trial target by year-end.

Drug Era Tech2025Year? How do they plan to mess around?

Drug Era BaiaoI heard that their upgraded chip, codenamed“Blindsight”, is expected to2025Year-End, First Implantation20to30in the patients' bodies, followed by several months of functional validation. The primary focus is on testing mind-controlled mouse operation, text input, and even simple drawing and typing.

PharmaEra TechWow, that sounds a bit exciting! So, what will the first-generation product truly aimed at us ordinary people be like?

Drug Era BaiaoThat product, they gave it a super cool name, calledTelepathyTelepathy). Ideally, you can unlock your phone just by thinking about it.APP, type to send WeChat messages, and control smart home devices——Completely free your hands and voice! It’s like turning your brain into a super touchpad.

Drug Era Tech If this can truly be achieved, won't we have to rely on it for typing in the future?Brainwaves?

Drug Era BaiaoI estimate that some people will be like this. Just as we are now inseparable from smartphones, there will certainly be a group of people in the future who will become increasingly dependent on them.Brain-Computer InterfaceOf course, to achieve widespread adoption, issues such as safety, stability, cost, and ethics must still be addressed.

Drug Era TechHearing you say that, I can’t help but want to give it a try! But I’m also worried: once this device is implanted, will it be like a smartphone, requiring annual upgrades? Would I have to undergo craniotomy just to swap in the latest model?

Drug Era BioAllHaha, your question is so vivid! However, if the technology matures, future improvements in user experience might be achieved through software and hardware upgrades, without necessarily requiring further surgical intervention. Much like updating a mobile phone’s operating system, the goal would be to minimize invasive procedures.

PharmaEra TechToday's discussion,Neuralinkbrain-computer interface has indeed opened a window to the future for us. We look forward to their ability to bring thisNeuralinktechnology into reality. Thank you for your professional interpretation!

Drug Era BaiaoYou're welcome. I also hope that more people will pay attention to the development of this field.


References:

1. Elon Musk’s Neuralink raises $600M at $9B valuation
2. Major News in Brain-Computer Interfaces! Elon Musk’s Neuralink Raises $600 Million, Valuation Hits $9 Billion (Tencent News)
3. Here It Comes! He’s Here! Tesla Rides the Wind and Waves, Charging into the Pharmaceutical Industry! (PharmaTimes Official Website)
4. Other Published Reports by Drug Era
5. Other Publicly Available Materials
图片
Image source: Internet

New Breakthrough in the Controversial Gut-Brain Axis: Rapid Changes in Brain Activity Alter Gut Microbiota, with Leptin as the Key

2025-05-31

Image

Antibody Drugs Go Global in Succession, with Total Value Exceeding $1.75 Billion

2025-05-30

Image

Biogen Pours Another $1 Billion into the CNS R&D Black Hole

2025-05-30

Image

Major Breakthrough! 11 Innovative Drugs Approved for Market in a Single Day! NMPA Makes Major Announcement

2025-05-29

Image

From 0% to 42%, Chinese Innovative Drugs Make History!

2025-05-28

Image

Leading iPSC Pharmaceutical Company’s Universal Cell Novel Drug Receives Seven Regulatory Clinical Trial Approvals from Chinese and U.S. Drug Authorities; Long-Term Follow-Up Demonstrates Safety and Efficacy in Cell Therapy for Parkinson’s Disease

2025-05-27

Image

Copyright Statement / Disclaimer

This article is an original work.

This article is for informational purposes only and does not provide any commercial, medical, or investment advice.

Images, videos, fonts, music, and other materials featured in this article are either licensed authentic works purchased by Pharmatimes, sourced from the WeChat public image library, or obtained from company websites/the internet. Some materials are used under the CC0 license. Copyright belongs to the respective owners, and Pharmatimes makes every effort to cite the sources.

Should you have any questions, please contact us.

Sincere thanks!

DrugTimes Official Website: www.drugtimes.cn

Contact Information:

Phone: 13651980212

WeChat: 27674131

Email: contact@drugtimes.cn

图片图片Click here to view the good news—check quickly to see if your company is listed! ~